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83,1-9. Certain organic phosphorus esters produce sensorimotor axonopathy in man and other species. There is an excellent correlation between the capacity of an organophosphorus compound to produce axonopathy and its ability to inhibit brain neurotoxic esterase (NTE) in hens. Because NTE is present in peripheral lymphocytes of both hen and man, it has been suggested that the lymphocyte enzyme might be useful both in experimental and clinical situations as an indicator of exposure to organophosphorus compounds producing axonopathy. Diethyl 4-nitrophenyl phosphate (paraoxon), tri-Zcresyl phosphate (TOCP), methyl 2,5dichloro+bromophenyl phenylphosphonothionate (leptophos), and di-n-butyl-2,2-dichlorovinyl phosphate (di-n-butyl dichlorvos, DBDCV) were used to examine the relationship between lymphocyte and brain NTE inhibition in hens. As expected, paraoxon (0.75 mgjkg) did not inhibit NTE in brain or lymphocytes. TOCP (10 to 100 mgjkg), leptophos (25 to 150 mg/kg), and DBDCV (1 .O to 4.0 mg/kg) inhibited both brain and lymphocyte NTE activity in a doserelated manner with good correlation of inhibition between tissues taken 24 hr after exposure (r2 = 0.53 to 0.67; p < 0.020 to 0.001). However, correlation of inhibition between tissues taken from animals killed 48 hr after exposures was poor (r' = 0.15 to 0.30; p < 0.10 to 0.05), with consistently less inhibition of lymphocyte NTE relative to brain NTE. This study indicates that assay of lymphocyte NTE can provide a good monitor of exposure to axonotoxic organophosphorus compounds within 24 hr between exposure and measurement. o 1986 Academic mess, IW.
Exposure to certain organic phosphorus esters produces sensorimotor neuropathy in humans. Adult laying hens (Gallus gallus domesticus) are used to provide a model of this condition for laboratory studies. Organophosphorus neuropathy is characterized morphologically as axonal degeneration, and both clinical and pathological alterations are delayed in onset, appearing 8 to 14 days following a single exposure to the toxic compound (Davis and Richardson, 1980; Johnson, 1982) . Organophosphorus compounds producing axonopathy phosphorylate and thereby inhibit neurotoxic esterase (NTE), an enzyme first identified in hen brain. NTE is resistant to compounds such as diethyl 4nitrophenyl phosphate (paraoxon) and tetraethyl pyrophosphate (TEPP), potent acetylcholinesterase inhibitors which do not produce neurodegeneration (Richardson, 1984) . There is an excellent correlation between the capacity of an organophosphorus compound to inhibit hen brain NTE by 70 to 90% within 1 to 2 days after dosing and the production of clinically evident axonopathy some 2 weeks later (Lotti phate, TOCP, practical grade) were purchased from Sigma and Johnson, 1978 and Johnson, , 1980 provided that the Chemical Company (St. Louis, MO.), Chem Service, Inc. compound is also subject to cleavage of a side (West Chester, Pa.) , and Eastman Kodak Company chain (aging) after the phosphorylation reac-(Rochester, N. Y.), respectively. Di-n-butyl-2,2-dichlotion has taken place (Johnson, 1974) .
rovinyl phosphate (di-n-butyl dichlorvos, DBDCV, 95% pure) was custom synthesized by Ash-Stevens, Inc. (De- It was first shown in our laboratory that pe-troit, Mich.). All other reagents for NTE and acetylchoripheral lymphocytes from the hen possess an linesterase assays were from Sigma Chemical Company, esteratic activity which behaves in a manner with the exception of 4-aminoantipyrine (Eastman Kodak identical to hen brain NTE with respect to in Co., 98% pure), and were used without further purification.
vitro substrate and inhibitor specificities, pH N,N'-di-2-propyl phosphorodiamidofluoridate (mipafox) and phenyl valerate (PV) were synthesized and purified optima, and heat inactivation rates (Dudek in our laboratory, according to methods described by and Richardson, , 1982 Richardson and Johnson (1977) . Aqueous solutions were prepared with Dudek, 1983) . NTE activity also exists in hudeionized-distilled water. man lymphocytes and platelets (Bleeker et al., 1983; Richardson and Dudek, 1983; Bertoncin Treatment Regimen et al., 1985) . If the time course and dose dependence of NTE inhibition in lymphocytes Paraoxon, TOCP, and DBDCV were mixed with corn were similar to those in brain, the assay of oil and introduced into the crop of hens (at least three per group) by steel gavage tube. Leptophos, a crystalline solid, lymphocyte NTE could be used to monitor Richardson and Dudek, 1983 Tris, 126 .0 mM NaCl, pH 7.6), and layered over FicollPaque density medium (Pharmacia Fine Chemicals, Piscataway, N.J.) in siliconized glass culture tubes. The tubes Adult (over 1 year old) white leghorn hens were obtained were centrifuged at 400gay8 for 30 min at 20°C. Lymphofrom Omega Chicks (Haslett, Mich.) at least 1 week prior cytes gathered at the density interface were collected with to experimentation. The birds were maintained (3 to 4 plastic transfer pipets and placed in clean siliconized tubes. per cage) in an air-conditioned room (21 to 23°C) on a Cells were washed twice by suspension in BSS and cen-12-hr light-dark cycle in 0.8 X 0.8 X 0.9-m stainless-steel trifugation at IOOOg,, for 10 min at 20°C. An aliquot of cages with wire bottoms. Except for the fasting procedure the final cell suspension was counted in a Model ZBI prior to dosing, animals were given Purina Layena mash Coulter counter (Coulter Electronics, Hialeah, Fla.), and (Ralston Purina, St. Louis, MO.) and tap water adlibitum.
the final pellet was stored at -8O'C for no more than 24 hr prior to NTE assay. Lymphocyte pellets were allowed Chemicals to thaw at room temperature, suspended in 2.00 ml of 50 mM Tris-HCl/O.ZO mM EDTA buffer (pH 8.00 at 25"C), and sonicated for 10 set at a power output of 50 W with Diethyl 4nitrophenylphosphate, methyl 2,5-dichloroa Branson cell disrupter (Branson Sonic Power, Danbury, 4-bromophenyl phenylphosphonothionate (leptophos, Conn.) fitted with a microtip which was immersed halfway 98% pure), and tri-2cresyl phosphate (tri-o-cresyl phos-into the suspension. The sonicate was then diluted with a sufficient volume of buffer to make a final concentration equivalent to 2.0 X 10' cells/ml.
Brain. Brains were rapidly removed from the skull at the time of death, blotted, weighed, and stored at -80°C for no more than 24 hr prior to NTE assay. After being allowed to thaw at room temperature, a 10% (w/v) homogenate of brain in ice-cold 50 mM Tris-HCl/O.ZO mM EDTA buffer (pH 8.00 at 25°C) was made with 10 strokes of a glass-tenon homogenizer (clearance approximately 0.25 mm) fitted to a 2300 rev/min drill press. An aliquot of this homogenate was diluted with buffer to a tissue concentration of 2.0 mg/ml.
Biochemical Assays
Neurotoxic esterase (NTE). NTE activity was assayed by calorimetric determination of the difference in phenol production by hydrolysis of PV between paired samples preincubated with paraoxon alone versus paraoxon plus mipafox. The procedure described by Johnson (1977) was modified and optimized for assay of both lymphocyte and brain NTE as follows: Tissue suspensions (equivalent to 1.0 mg brain or 1.0 X IO' lymphocytes) in 0.50 ml of buffer (50 mM Tris-HCI/O.ZO mM EDTA, pH 8.00 at 25°C) were mixed at zero time with 0.50 ml of buffer containing either 200 pM paraoxon or 200 pM paraoxon plus 100 pM mipafox and preincubated for exactly 20 min in a circulating water bath at 37°C. PV (30 mg dissolved in 1 .O ml of dimethylformamide) was mixed with 30.0 ml of 0.03% (w/v) aqueous Triton X-100 to make a micellar suspension and 1 .OO ml of this substrate mixture was added to the preincubate at the end of the 20-min preincubation period. The reaction with substrate was allowed to proceed for exactly 30 min before stopping with 1 .OO ml of 1 .O% (w/v) sodium dodecyl sulfate in 500 mM Tris-HCl buffer (pH 9.00 at 25°C) containing 0.025% (w/v) 4-aminoantipyrine. Color was developed at room temperature by adding 0.50 ml of aqueous 0.40% (w/v) potassium ferricyanide and its absorbance was measured at 5 10 nm relative to deionized-distilled water in a Sequoia-Turner Model 340 spectrophotometer (Mountain View, Calif.). The absorbance difference between paired tubes preincubated with paraoxon alone versus paraoxon plus mipafox has been operationally defined to be due to hydrolysis of PV by NTE (Johnson and Richardson, 1983) and that value was used for specific activity determination. The molar absorptivity at 5 10 nm for the color product was determined from phenol standards to be 13,900 M-' cm-'. Because of the differential nature of the assay, tissue and reagent blanks are automatically subtracted. However, a reagent blank was routinely included as a check on the free phenol content of the substrate. Specific enzyme activity was calculated as nmol substrate hydrolyzed/min X mg protein. Percentage enzyme inhibition was calculated by dividing the specific enzyme activity in individual tissues from treated animals by the mean specific activity in controls, subtracting this ratio from 1.00, and multiplying by 100.
Acetylcholinesterase.
Brain acetylcholinesterase (AChE) was assayed by a modification of the method of Ellman et al. ( 196 l) , which has been previously described (Schwab and Murphy, 198 1) . Specific activity and enzyme inhibition were calculated as for NTE.
Protein. Protein was assayed using the Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond, Calif.) based on Bradford's dye-binding method (Bradford, 1976) . Bovine serum albumin, fraction V (Sigma Chemical Co.), was used as a reference standard.
Statistical Analysis
To determine the statistical significance of the effect of paraoxon on brain AChE and brain lymphocyte NTE, unpaired t tests were performed on the mean values obtained from tissues from treated versus control animals. Linear regression analysis was used to examine the correlation of NTE inhibition between tissues in animals given TOCP, leptophos, or DBDCV 24 or 48 hr prior to killing. Brain inhibition (on the ordinate) was paired with lymphocyte inhibition (abscissa) from the same animal and regression lines were fitted to the data for each compound at each of the two time points using the method of least squares. Inference on the correlation of inhibition between tisues was made by t test on the coefficient of determination (r') of the regression lines. The null hypothesis in this test is that r2 is equal to zero, i.e., that no correlation exists (Goldstein, 1964) . Additionally, paired t tests were performed on the values obtained for brain and lymphocyte NTE inhibition from each individual dosing group. Where mean values for data are presented, +SE is also given, with the number of observations (animals) indicated in parentheses; p < 0.05 was regarded as significant for t tests.
RESULTS
All animals survived exposure to the test compounds. Dosed animals appeared to be less active in their cages than controls following dosing, but the only unequivocal clinical difference detected between treated and control animals occurred in paraoxon-dosed birds.
Paraoxon, 0.75 mg/kg, inhibited brain AChE by 56 + 4% (n = 16, p < 0.001) and produced mild cholinergic signs (muscle fasciculations). This dose did not significantly inhibit either brain or lymphocyte NTE. Mean inhibition was 1 + 2% and 7 + 8% for brain and lymphocytes, respectively (relative to respective control activities of 5 1.2 + 0.85 nmol and 9.92 + 0.68 nmol PV hydrolyzedlmin X mg protein; n = 7).
TOCP, leptophos, and DBDCV inhibited brain and lymphocyte NTE in a dose-responsive manner. When measured in tissues from animals killed 24 hr after exposure, there was good agreement between brain and lymphocyte NTE inhibition. Coefficients of determination (r*) were 0.67 (n = 12, p < O.OOS), 0.53 (I? = 11, p < 0.020), and 0.53 (n = 18, p < 0.001) for TOCP, leptophos, and DBDCV regressions, respectively. Observations on tissues taken 48 hr after exposure contrasted with the previous data. Coefficients of determination were lower in all regressions of 48 hr data, and significantly different from zero only for DBDCV. The 48-hr r* values were 0.15 (n = 22, 0.05 < p < O.lO), 0.30 (n = 11, 0.05 < p < O.lO), and 0.30 (n = 16, p < 0.05) for TOCP, leptophos, and DBDCV, respectively. Scattergrams and fitted regression lines of these data are presented in Figs. 1 to 3 .
Mean NTE inhibition in brain and lymphocytes from the 10 dosing groups killed 24 hr after exposure are presented in Figs. 4 to 6. NTE inhibition was similar for brain and lymphocytes in most groups. Statistically significant differences in brain versus lymphocyte inhibition were seen in only 2 of these groups (TOCP, 50 mg/kg; and leptophos, 25 mg/kg), and the direction of the differences were opposite. There were 9 dosing groups killed 48 hr after exposure (a 1 mg/kg DBDCV group was included at 24 hr but not at 48 hr). Mean inhibition data from these animals are presented in Figs. 4 to 6. At 48 hr, the mean NTE inhibition value of lymphocytes was lower than that observed in brain in every case, with the difference being statistically significant in 4 of the groups (TOCP, 50 and 100 mg/kg; leptophos, 75 mg/kg; and DBDCV, 3 mg/kg).
DISCUSSION
It would be useful in both clinical and experimental situations to be able to easily monitor absorption of axonotoxic organophosphorus compounds. Many of these compounds produce no acute signs, so that the first indication of toxic exposure would be the onset of peripheral neuropathy some weeks following insult. It would be preferable to have a system capable of indicating systemic absorption in much shorter periods of time and sensitive enough to disclose situations which should be interrupted before sufficient exposure had occurred to cause overt toxic damage. In experimental animals, brain NTE inhibition may be reliably measured within a few hours following exposure to axonotoxic organophosphorus compounds at doses below the threshold for detection of clinically apparent neuropathy (Johnson and Richardson, 1983) . However, there are practical limitations to a brain assay. Clearly, it is usually not possible or desirable to obtain central nervous system tissue from patients. Likewise, in studies with experimental animals, obtaining data on brain NTE inhibition often entails killing one group of animals while a pair-dosed group is used for further procedures. Our present and past (Richardson and Dudek, 1983) observations suggest that assay for inhibition of lymphocyte NTE up to 24 hr after exposure to an organophosphorus compound may be used in lieu of assay of brain tissue to indicate the axonopathic potential of an exposure. An obvious advantage of lymphocyte monitoring is that tissue for assay may be obtained relatively innocuously.
While lymphocyte measurements have good potential as a monitor of acute exposures to axonotoxic organophosphorus compounds in both experimental and clinical situations, our results suggest that lymphocyte NTE assays are limited in their applicability with respect to the period between exposure and measurement. At 48 hr after exposure, there is poor correlation between NTE inhibition in brain versus lymphocytes and it is not likely that much insight about the exposure or its consequences could be gained from lymphocyte assay at this time point. The unsatisfactory correlation between brain and lymphocytes 48 hr after an acute dose of an axonotoxic (0) and lymphocyte (a) NTE in hens given 10, 50, or 100 mg/kg TOCP po, either 24 or 48 hr prior to killing. At 24 hr, there were no significant differences between brain and lymphocyte NTE inhibitions at 100 (n = 3) or 10 mg/kg (n = 4), but lymphocyte NTE inhibition was significantly less than brain NTE inhibition at 50 mg/kg (n = 3, p < 0.05; paired t test). At 48 hr, mean percentage inhibition of lymphocyte NTE was consistently lower than that for brain in all dosage groups; the differences were significant (paired t test) for 100 mg/kg (n = 8, p i 0.05) and 50 mg/ kg (n = 6, p < O.Ol), but not for 10 mg/kg (n = 8, p > 0.05).
organophosphorus compound is reminiscent of the lack of correspondence between brain and lymphocyte inhibition reported by Lotti and Johnson ( 1980) following subchronic exposure of hens to mono-2-cresyl diphenyl phosphate. It would be profitable to study the biological events which undo correlation between brain and lymphocyte NTE at 48 hr, in case they might in some way be circumvented. An alternative approach may be to use another blood component with NTE activity, such as platelets (Bleeker et al., 1983; Richardson and Dudek, 1983) , but studies on the stability and dose dependency of inhibition of NTE in these blood elements are incomplete.
Animals killed 48 hr after exposure to the test compounds also had consistently less NTE inhibition in lymphocytes relative to brain. We presume that the divergence of brain and lymphocyte NTE inhibition is due to dissimilar kinetics of reappearance of enzyme activity. Return of activity of an inhibited enzyme may proceed by reactivation of the inhibited en- (0) and lymphocyte (kB) in hens given 25, 75, or 150 mg/kg leptophos po, either 24 or 48 hr prior to killing. At 24 hr, there were no significant differences between brain and lymphocyte NTE inhibitions at 150 (n = 4) or 75 mg/kg (n = 4), but lymphocyte NTE inhibition was significantly greater than brain NTE inhibition at 25 mg/kg (n = 4, p < 0.05; paired t test). At 48 hr, mean percentage inhibition of lyphocyte NTE was consistently lower than that for brain in all dosage groups; the difference was significant hr, there were no significant differences 0, > 0.05, paired t test) between brain and lymphocyte NTE inhibition for any dosage group (n = 3, 6, 6, and 3 for the 1.0, 2.0, 3.0, and 4.0 mg/kg groups, respectively). At 48 hr, mean percentage inhibition of lymphocyte NTE was consistently lower than that for brain in all dosage groups; the difference was significant (paired t test) for 3.0 mg/kg (n = 7, p < 0.05). but not for 4.0 (n = 3) or 2.0 mg/kg (n = 6).
zyme, de ~OVO enzyme (protein) synthesis, or turnover of cells containing the activity. Resynthesis of enzyme is believed to be the mechanism of return of NTE activity in neural tissue, as reactivation by dephosphorylation has been shown to be slight and nervous system tissue is not comprised of cell populations with high rates of turnover (Johnson, 1982; Richardson, 1984) . The relative contributions of different mechanisms for recovery of NTE activity in lymphocytes have not been studied. In contemplating such studies, one should consider more than the normal rates of protein or cell turnover in lymphocytes. Indeed, there are reports indicating that treatment with organophosphorus compounds may alter the function or the constituents of the lymphocyte population (Watanabe and Sharma, 1977; Foil et al., 1981; Ehrich and Gross, 1983) .
Comparative studies of avian and mammalian systems using both acute and chronic exposures may be useful in interpreting results of lymphocyte NTE measurements in humans. Lotti er al., (1983) have conducted a field study of seven workers exposed daily for up to 34 days to S,S,S-tributylphosphorotrithiolate (DEF) and tributylphosphorotrithioite (merphos), in which decreases in lymphocyte NTE of approximately 50% of preexposure values were reported between days 25 and 30 of exposure, with no concomitant signs or symptoms of neurological abnormalities detected in any of the subjects at any time during the exposure or at 3 weeks after termination of exposure. This would indicate a positive response of human lymphocyte NTE following exposure to organophosphorus compounds with experimentally demonstrated axonotoxic potential (Davis et al., 1985) . In view of the lack of detectable neurological abnormalities in the exposed humans, the NTE inhibition in each individual's nervous system was presumably below the threshold required for expression of clinical effects, although no neural tissue was available for determination of correlation.
The fact that the NTE assay is quantitative makes it useful for ranking the relative potency of axonopathic organophosphorus compounds as well as discovering axonopathic potential at subclinical doses. However, the oftenquoted "threshold" of approximately 70% inhibition of whole-brain NTE following an acute exposure (Johnson and Richardson, 1983) should not be taken as an absolute correlate of the dividing line between the subsequent presence or absence of neuropathy. We found that 100 mg/kg TOCP produced brain NTE inhibitions of 69 and 75% at 24 and 48 hr, respectively, whereas the ED50 for clinically apparent neuropathy has been reported to be 200 to 250 mg/kg (Aldridge and Barnes, 196 1; Watanabe and Sharma, 1976) . Neuropathy is not generally seen at lower doses because the dose-response curve for inhibition of hen brain NTE 24 hr after a single oral dose of TOCP rises sharply to an ED50 of 40 mg/ kg and then becomes relatively flat, so that inhibition increases from 70 to 95% between 100 and 1000 mg/kg; to ensure obvious clinical neuropathy, doses of 500 to 1000 mg/kg are commonly used (Dudek, 1979) . Likewise, Lotti and Johnson ( 1980) found that 80 to 90% inhibition is required for unequivocal clinical neuropathy from single oral doses of mono-2-cresyl diphenylphosphate.
Route of administration and chemical purity may affect the amount of active inhibitor that reaches the target, so that the inclusion of NTE inhibition data is much more informative than merely stating the dose required to produce neuropathy. Thus, we found that dosing po with 3.0 mg/kg DBDCV produced only 64% inhibition of brain NTE at 24 hr, but in independent work in our laboratory (Huggins, 1982) dosing SC with 2.8 mg/kg DBDCV was sufficient to nroduce >80% inobjective and quantifiable endpoints such as histopathological and electrophysiological changes would be helpful in determining whether subclinical damage is produced by lower levels of NTE inhibition than have heretofore been associated with the production of neuropathy.
Future work on lymphocyte NTE should further explore the advantages and limitations of its use as a biomonitor of axonotoxic organophosphorus compound exposure. Moreover, the possibility that NTE may be involved in functional or pathological interrelationships between the nervous system and the immune system certainly deserves further study (Dudek and Richardson, 1982) . Proteins expressed in greatest concentration in brain and lymphocytes, such as NTE (Dudek and Richardson, 1982; Williams, 1983 ) may be part of such relationships as has been demonstrated or postulated for other proteins with similar distribution (Barclay and Hyden, 1978; Golub, 1982; McKenzie et al., 1982) .
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